<DOC>
	<DOCNO>NCT01016899</DOCNO>
	<brief_summary>The objective study record recurrence patient treat nonmelanoma ( basal cell squamous cell carcinoma ) skin cancer use Xoft Axxent Electronic Brachytherapy System . Additional objective include evaluate appearance treat area patient treat nonmelanoma skin cancer use Xoft Axxent Electronic Brachytherapy System record occurrence radiation therapy relate skin change patient treat nonmelanoma skin cancer .</brief_summary>
	<brief_title>Electronic Brachytherapy Treatment NMSC</brief_title>
	<detailed_description>The objective study record local recurrence patient treat nonmelanoma ( basal cell squamous cell carcinoma ) skin cancer use Xoft Axxent Electronic Brachytherapy System . Additional objective include evaluate cosmetic outcome patient treat nonmelanoma skin cancer use Xoft Axxent Electronic Brachytherapy System record occurrence radiation therapy relate skin toxicity patient treat nonmelanoma skin cancer use Xoft Axxent Electronic Brachytherapy System .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<criteria>Patient sign informed consent form Pathological diagnosis confirm squamous cell basal cell carcinoma Histopathological Grade : G1 ( well differentiate ) , G2 ( moderately differentiate ) , Gx ( Not assess report ) Clinical Staging Tis , T1 , T2 ( Must â‰¤ 4 cm diameter ) One lesion treat , 1 lesion treat minimum 5 mm gap edge lesion margin . T2 &gt; 4 cm T3 T4 American Joint Committee Staging NMSC Stages III IV Histopathologic Grade 3 ( poorly differentiate ) high grade Target area adjacent burn scar Target area lip Patient &lt; 50 year age Any prior definitive surgical resection cancer Perineural invasion Lesion depth &gt; 5mm clinical assessment assess ultrasound CT . Patient pregnant ( pregnancy test require standard care ) . Target area prone trauma . Target area compromise lymphatic vascular drainage . Participation another investigational device drug study concurrently . Patient undergone prior radiation therapy specific anatomic location . Patient receive pharmacologic agent ( ) around time Radiation therapy is/are know produce skin reaction influence cosmesis grading study . Patient receive chemotherapeutic agent ( ) Six ( 6 ) week six ( 6 ) week radiation therapy . Life expectancy less five ( 5 ) year .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Electronic</keyword>
	<keyword>Brachytherapy</keyword>
	<keyword>Nonmelanoma</keyword>
	<keyword>cancer</keyword>
</DOC>